105 related articles for article (PubMed ID: 29519853)
1. Cooperative Regulation of Intestinal UDP-Glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4
Mubarokah N; Hulin JA; Mackenzie PI; McKinnon RA; Haines AZ; Hu DG; Meech R
Mol Pharmacol; 2018 May; 93(5):541-552. PubMed ID: 29519853
[TBL] [Abstract][Full Text] [Related]
2. Coordinate regulation of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 genes by hepatocyte nuclear factor 1alpha and the caudal-related homeodomain protein 2.
Gregory PA; Lewinsky RH; Gardner-Stephen DA; Mackenzie PI
Mol Pharmacol; 2004 Apr; 65(4):953-63. PubMed ID: 15044625
[TBL] [Abstract][Full Text] [Related]
3. Regulation of UDP glucuronosyltransferases in the gastrointestinal tract.
Gregory PA; Lewinsky RH; Gardner-Stephen DA; Mackenzie PI
Toxicol Appl Pharmacol; 2004 Sep; 199(3):354-63. PubMed ID: 15364550
[TBL] [Abstract][Full Text] [Related]
4. Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alpha.
Barbier O; Girard H; Inoue Y; Duez H; Villeneuve L; Kamiya A; Fruchart JC; Guillemette C; Gonzalez FJ; Staels B
Mol Pharmacol; 2005 Jan; 67(1):241-9. PubMed ID: 15470081
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte nuclear factor1 transcription factors are essential for the UDP-glucuronosyltransferase 1A9 promoter response to hepatocyte nuclear factor 4alpha.
Gardner-Stephen DA; Mackenzie PI
Pharmacogenet Genomics; 2007 Jan; 17(1):25-36. PubMed ID: 17264800
[TBL] [Abstract][Full Text] [Related]
6. The caudal-related homeodomain protein Cdx2 and hepatocyte nuclear factor 1alpha cooperatively regulate the UDP-glucuronosyltransferase 2B7 gene promoter.
Gregory PA; Gardner-Stephen DA; Rogers A; Michael MZ; Mackenzie PI
Pharmacogenet Genomics; 2006 Jul; 16(7):527-36. PubMed ID: 16788384
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region.
Gregory PA; Gardner-Stephen DA; Lewinsky RH; Duncliffe KN; Mackenzie PI
J Biol Chem; 2003 Sep; 278(38):36107-14. PubMed ID: 12847094
[TBL] [Abstract][Full Text] [Related]
8. Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10.
Mizuma T
Int J Pharm; 2009 Aug; 378(1-2):140-1. PubMed ID: 19486934
[TBL] [Abstract][Full Text] [Related]
9. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the tissue-specific expression of human UDP-glucuronosyltransferase (UGT) 1A10.
Oda S; Fukami T; Yokoi T; Nakajima M
Biochem Pharmacol; 2014 Feb; 87(4):660-7. PubMed ID: 24239897
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of inhibitors of intestinal UDP-glucuronosyltransferases 1A8 and 1A10 using raloxifene as a substrate in Caco-2 cells: Studies with four flavonoids of Scutellaria baicalensis.
Chang CF; Chang YC; Lin JT; Yu CW; Kao YT
Toxicol In Vitro; 2021 Apr; 72():105087. PubMed ID: 33440186
[TBL] [Abstract][Full Text] [Related]
12. Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.
Cheng Z; Radominska-Pandya A; Tephly TR
Drug Metab Dispos; 1999 Oct; 27(10):1165-70. PubMed ID: 10497143
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies of human UDP-glucuronosyltransferase 1A8 and 1A9 proximal promoters using single base substitutions.
Xiao Z; Nunome K; Yahara T; Inoue E; Nabeshima M; Tsuchida S; Hamaue N; Aoki T
Drug Metab Pharmacokinet; 2014; 29(1):90-3. PubMed ID: 23842475
[TBL] [Abstract][Full Text] [Related]
14. How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?
Itäaho K; Laakkonen L; Finel M
Drug Metab Dispos; 2010 Apr; 38(4):687-96. PubMed ID: 20089735
[TBL] [Abstract][Full Text] [Related]
15. 1-Alpha, 25-dihydroxyvitamin D3 alters the pharmacokinetics of mycophenolic acid in renal transplant recipients by regulating two extrahepatic UDP-glucuronosyltransferases 1A8 and 1A10.
Wang X; Wang H; Shen B; Overholser BR; Cooper BR; Lu Y; Tang H; Zhou C; Sun X; Zhong L; Favus MJ; Decker BS; Liu W; Peng Z
Transl Res; 2016 Dec; 178():54-62.e6. PubMed ID: 27496319
[TBL] [Abstract][Full Text] [Related]
16. HNF4α and CDX2 Regulate Intestinal
Larsen S; Davidsen J; Dahlgaard K; Pedersen OB; Troelsen JT
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216773
[TBL] [Abstract][Full Text] [Related]
17. Shared regulation of UGT1A7 by hepatocyte nuclear factor (HNF) 1alpha and HNF4alpha.
Ehmer U; Kalthoff S; Lankisch TO; Freiberg N; Manns MP; Strassburg CP
Drug Metab Dispos; 2010 Jul; 38(7):1246-57. PubMed ID: 20406851
[TBL] [Abstract][Full Text] [Related]
18. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8.
Strassburg CP; Manns MP; Tukey RH
J Biol Chem; 1998 Apr; 273(15):8719-26. PubMed ID: 9535849
[TBL] [Abstract][Full Text] [Related]
19. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M
Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014
[TBL] [Abstract][Full Text] [Related]
20. Glucuronidation of mono(2-ethylhexyl) phthalate in humans: roles of hepatic and intestinal UDP-glucuronosyltransferases.
Hanioka N; Kinashi Y; Tanaka-Kagawa T; Isobe T; Jinno H
Arch Toxicol; 2017 Feb; 91(2):689-698. PubMed ID: 27071666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
